References
- Barranco S.C. Review of the survival and cell kinetics effects of adriamycin (NSC-123127) on mammalian cells. Cancer Chemotherapy Reports Part 3 1975; 6: 147–152
- Belli J.A., Harris J.R. Adriamycin resistance and radiation response. International Journal of Radiation Oncology, Biology and Physics 1979; 5: 1231–1234
- Belli J.A., Piro A.J. The interaction between radiation and adriamycin damage in mammalian cells. Cancer Research 1977; 37: 1624–1630
- Bistrovic M., Wagy N., Maricic Z., Kolaric K. Interaction of adriamycin and radiation in combination treatment on mouse L-cells. European Journal of Cancer 1978; 14: 411–414
- Bradley M.O., Kohn K.W. X-ray induced DNA double-strand break production and repair in mammalian cells as measured by neutral filter elution. Nucleic Acids Research 1979; 7: 793–804
- Byfield J.E., Lee Y.C., Tu L. Molecular interactions between adriamycin and x-ray damage in mammalian tumor cells. International Journal of Cancer 1977a; 19: 186–193
- Byfield J.E., Lynch M., Kulhanian F., Chan P.Y.M. Cellular effects of combined adriamycin and x-irradiation in human tumor cells. International Journal of Cancer 1977b; 19: 194–204
- Colton T. Statistics in Medicine. Little, Brown, Boston 1974
- Dewey W.C., Noel J.S., Dettor C.M. Changes in radiosensitivity and dispersion of chromatin during the cell cycle of synchronous chinese hamsters cells. Radiation Research 1972; 52: 373–394
- Elkind M.M. DNA damage and cell killing: cause and effect?. Cancer 1985; 56: 2351–2363
- Fertil B., Dertinger H., Courdi A., Malaise E.P. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiation Research 1984; 99: 73–84
- Fornace A.J., Jr., Kohn K.W. DNA-protein cross-linking by ultraviolet radiation in normal and xeroderma pigmentosum fibroblasts. Biochimica et Biophysica Acta 1976; 435: 95–103
- Glisson B.S., Ross W.E. DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy. Pharmacology and Therapeutics 1987; 32: 89–106
- Lawrence T.S. Reduction of doxorubicin cytotoxicity by ouabain: correlation with topoisomerase-induced DNA strand breakage in human and hamster cells. Cancer Research 1988; 48: 725–730
- Lee Y.C., Chan P.Y.M., Bennett L.R., Byfield J.E. X-ray repair replication of L-1210 leukemia cells. Cancer Research 1974; 34: 2624–2633
- Myers C., Muindi J., Batist G., Haim N., Sinha B.K. Anthracyclines. Cancer Chemotherapy, H.M. Pinedo, B.A. Chabner. Elsevier, New York 1985; 7: 57–75
- Robson C.N., Hoban P.R., Harris A.L., Hickson I.D. Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive chinese hamster ovary cell lines. Cancer Research 1987; 47: 1560–1565
- Roots R., Okada S. Protection of DNA molecules of cultured mammalian cells from radiation induced single-strand scissions by various alcohols and SH compounds. International Journal of Radiation Biology 1972; 21: 329–342
- Ross W.E., Glaubiger D.L., Kohn K.W. Protein-associated DNA breaks in cells treated with adriamycin or ellipticine. Biochemica et Biophysica Acta 1978; 519: 23–30
- Skovsgaard T. Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells. Biochemical Pharmacology 1977; 26: 215–222
- Ward J.F. Biochemistry of DNA lesions. Radiation Research 1985; 140: 103–111
- Ward J.F. Mechanisms of DNA repair and their potential modification for radiotherapy. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1027–1032
- Ward J.F., Joner E.I., Blakely W.F. Effects of inhibitors of DNA strand break repair on HeLa cell radiosensitivity. Cancer Research 1984; 44: 59–63
- Watring W.G., Byfield J.E., Lagasse L.D., Lee Y.C., Juillard G., Jacobs M., Smith M.L. Combination adriamycin and radiation therapy in gynecologic cancers. Gynecology and Oncology 1974; 2: 518–526
- Zwelling L.A., Kerrigan D., Michaels S. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4′-(9-acridinylamino)methanesulfon-m-anisidide. Cancer Research 1982; 42: 2687–2691
- Zwelling L.A., Michaels S., Erickson L.C., Ungerieider R.S., Nichols M., Kohn K.W. Protein associated deoxyribonucleic acid strand breaks in L1210 cells treated with deoxyribonucleic acid intercalating agents 4′-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. Biochemistry 1981; 20: 6553–6563
- Zwelling L.A., Silberman L., Estey E. Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1041–1047